Prostate Cancer - Results from #20420

Time and labor costs associated with administration of intravenous bisphosphonates for breast or prostate cancer patients with metastatic bone disease: A time and motion study - Abstract June 7, 2014

Targeting DNA repair with combination veliparib (ABT-888) and temozolomide in patients with metastatic castration-resistant prostate cancer - Abstract June 7, 2014

Nadir PSA level and time to nadir PSA are prognostic factors in patients with metastatic prostate cancer - Abstract June 7, 2014

Prostate cancer: Role of pretreatment multiparametric 3-T MRI in predicting biochemical recurrence after radical prostatectomy - Abstract June 6, 2014

New developments in the treatment of castration resistant prostate cancer - Abstract June 6, 2014

The impact of prostate cancer on partners: A qualitative exploration - Abstract June 6, 2014

Adherence patterns for abiraterone acetate and concomitant prednisone use in patients with prostate cancer - Abstract June 6, 2014

Recent advances in bone-targeted therapies of metastatic prostate cancer - Abstract June 6, 2014

Genomic, pathological, and clinical heterogeneity as drivers of personalized medicine in prostate cancer - Abstract June 6, 2014

Standardized report for early complications of radical prostatectomy - Abstract June 6, 2014

The impact of radical prostatectomy operative time on outcomes and costs - Abstract June 6, 2014

Survival of men with prostate cancer undergoing radical prostatectomy in Ontario - Abstract June 6, 2014

Optimization of prostate biopsy: The role of MRI targeted biopsy in detection, localization, and risk assessment - Abstract June 6, 2014

PROSTVAC® targeted immunotherapy candidate for prostate cancer - Abstract June 5, 2014

Advanced imaging for the early diagnosis of local recurrence prostate cancer after radical prostatectomy - Abstract June 5, 2014

Absorbable hydrogel spacer use in men undergoing prostate cancer radiotherapy: 12 Month toxicity and proctoscopy results of a prospective multicenter phase II trial - Abstract June 5, 2014

Triage of low-risk prostate cancer patients with PSA levels 10 ng/mL or less: Comparison of apparent diffusion coefficient value and transrectal ultrasound-guided target biopsy - Abstract June 4, 2014

Improving intermittent androgen deprivation therapy: Lessons learned from basic and translational research - Abstract June 4, 2014

Effect of magnesium oxide on interfraction prostate motion and rectal filling in prostate cancer radiotherapy: Analysis of a randomized clinical trial - Abstract June 4, 2014

Radiobiological impact of planning techniques for prostate cancer in terms of tumor control probability and normal tissue complication probability - Abstract June 4, 2014

Page 1022 of 1435